Virtual screening for potential inhibitors of human hexokinase II for the development of anti-dengue therapeutics
Dengue fever, which is a disease caused by the dengue virus (DENV), is a major unsolved issue in many tropical and sub-tropical regions of the world. The absence of treatment that effectively prevent further viral propagation inside the human’s body resulted in a high number of deaths globally each...
Saved in:
Main Authors: | Tanbin, Suriyea, Ahmad Fuad, Fazia Adyani, Abdul Hamid, Azzmer Azzar |
---|---|
Format: | Article |
Language: | English English |
Published: |
MDPI AG
2021
|
Subjects: | |
Online Access: | http://irep.iium.edu.my/87153/1/87153_Virtual%20Screening%20for%20Potential%20Inhibitors%20of%20Human%20Hexokinase_ft%20%282%29.pdf http://irep.iium.edu.my/87153/7/87153_Virtual%20screening%20for%20potential%20inhibitors_SCOPUS.pdf http://irep.iium.edu.my/87153/ https://www.mdpi.com/2673-6284/10/1/1 https://doi.org/10.3390/biotech10010001 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Virtual screening for potential inhibitors of human hexoki-nase ii for the development of anti-dengue therapeutics
by: Ahmad Fuad, Fazia Adyani, et al.
Published: (2020) -
Novel compounds as potential anti-dengue therapies verified via inhibition of human hexokinase isoform II
by: Tanbin, Suriyea, et al.
Published: (2020) -
Interrogating novel compounds for improved anti-dengue therapies via inhibition of human hexokinase II (HKII)
by: Ahmad Fuad, Fazia Adyani, et al.
Published: (2020) -
Elucidating the analogues of 3-bromopyruvate (3-BP) as inhibitors against human hexokinase II for the development of anti-dengue drugs
by: Tanbin, Suriyea, et al.
Published: (2019) -
Enhanced expression and purification strategy for recombinant bacterially-expressed human hexokinase II
by: Ahmad Fuad, Fazia Adyani, et al.
Published: (2021)